Brief: Cara Therapeutics receives payments for development of CR845 in Uremic Pruritus13/10/2015 13:00
Brief: Zafgen enters into subscription agreement with Chong Kun Dang Pharmaceutical Corp - SEC filing21/11/2014 22:02
Last trade - 00:00Last trade - 00:00Last trade - 00:00